Insider · CIK 0001846905

Bhanji Muna

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001846905

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	VCYTVERACYTE, INC.S Sale	Director	SSale	−1,864 sh	$42.97	−$80.1K	42,718
2026-06-16	ARDXARDELYX, INC.A Award	Director	AAward	+26.5K sh	—	—	163,808
2026-06-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+39.7K sh	—	—	39,715
2026-06-11	VCYTVERACYTE, INC.A Award	Director	AAward	+5,272 sh	—	—	44,582
2026-06-09	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+9,200 sh	—	—	36,403
2026-06-09	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,300
2026-05-27	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+4,301 sh	—	—	4,301
2026-05-27	CYTKCYTOKINETICS INCA Award	Director	AAward	+2,851 sh	—	—	26,361
2025-06-18	ARDXARDELYX, INC.A Award	Director	AAward	+41.6K sh	—	—	137,353
2025-06-18	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+54.1K sh	—	—	54,059
2025-06-18	VCYTVERACYTE, INC.A Award	Director	AAward	+9,321 sh	—	—	39,310
2025-06-13	VCYTVERACYTE, INC.S Sale	Director	SSale	−4,589 sh	$26.67	−$122K	29,989
2025-06-11	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,450
2025-06-11	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+8,000 sh	—	—	27,203
2025-05-15	CYTKCYTOKINETICS INCS Sale	Director	SSale	−1,454 sh	$29.73	−$43.2K	23,510
2025-05-14	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+10.9K sh	—	—	10,880
2025-05-14	CYTKCYTOKINETICS INCA Award	Director	AAward	+7,333 sh	—	—	24,964
2025-04-29	NTLAIntellia Therapeutics, Inc.S Sale	Director	SSale	−265 sh	$8.50	−$2,252.5	19,203
2025-01-29	NTLAIntellia Therapeutics, Inc.S Sale	Director	SSale	−265 sh	$9.97	−$2,642.05	19,468
2024-06-14	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40.2K sh	—	—	40,243
2024-06-13	VCYTVERACYTE, INC.A Award	Director	AAward	+11.5K sh	—	—	34,578
2024-06-12	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+7,737 sh	—	—	19,733
2024-06-12	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,515
2024-06-10	VCYTVERACYTE, INC.S Sale	Director	SSale	−3,870 sh	$20.32	−$78.6K	23,105
2024-06-10	CYTKCYTOKINETICS INCS Sale	Director	SSale	−2,000 sh	$52.07	−$104K	17,631
2024-05-28	VCYTVERACYTE, INC.S Sale	Director	SSale	−1,539 sh	$21.00	−$32.3K	26,975
2024-05-15	CYTKCYTOKINETICS INCA Award	Director	AAward	+5,600 sh	—	—	19,631
2024-05-15	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+3,636 sh	—	—	3,636
2023-10-31	NTLAIntellia Therapeutics, Inc.S Sale	Director	SSale	−265 sh	$23.90	−$6,333.5	11,996
2023-07-31	NTLAIntellia Therapeutics, Inc.S Sale	Director	SSale	−265 sh	$42.33	−$11.2K	12,261
2023-07-07	CYTKCYTOKINETICS INCS Sale	Director	SSale	−2,000 sh	$34.12	−$68.2K	14,031
2023-07-06	NTLAIntellia Therapeutics, Inc.S Sale	Director	SSale	−1,867 sh	$39.30	−$73.4K	12,526
2023-06-16	VCYTVERACYTE, INC.S Sale	Director	SSale	−5,793 sh	$26.42	−$153K	28,614
2023-06-16	VCYTVERACYTE, INC.S Sale	Director	SSale	−100 sh	$27.09	−$2,709	28,514
2023-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+49.2K sh	—	—	49,237
2023-06-14	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,473 sh	—	—	6,473
2023-06-14	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+4,425 sh	—	—	14,393
2023-06-09	VCYTVERACYTE, INC.A Award	Director	AAward	+9,674 sh	—	—	34,407
2023-05-30	VCYTVERACYTE, INC.S Sale	Director	SSale	−1,539 sh	$25.91	−$39.9K	24,733
2023-05-10	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-05-10	CYTKCYTOKINETICS INCA Award	Director	AAward	+5,000 sh	—	—	16,031
2022-10-03	CYTKCYTOKINETICS INCA Award	Director	AAward	+220 sh	$51.11	+$11.2K	11,031
2022-07-01	CYTKCYTOKINETICS INCA Award	Director	AAward	+274 sh	$41.00	+$11.2K	10,811
2022-06-16	VCYTVERACYTE, INC.A Award	Director	AAward	+14.7K sh	—	—	26,272
2022-06-15	ARDXARDELYX, INC.A Award	Director	AAward	+95.8K sh	—	—	95,802
2022-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-06-14	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,980 sh	—	—	2,980
2022-06-14	NTLAIntellia Therapeutics, Inc.A Award	Director	AAward	+2,014 sh	—	—	9,968
2022-05-10	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-05-10	CYTKCYTOKINETICS INCA Award	Director	AAward	+5,000 sh	—	—	10,537

Recent filings

Accepted (ET)
Sep 34
Bhanji Muna0001846905-26-000006
SEC(opens sec.gov)
Jun 184
Bhanji Muna0001846905-26-000004
SEC(opens sec.gov)
Jun 154
Bhanji Muna0001846905-26-000002
SEC(opens sec.gov)
Jun 104
Bhanji Muna0001193125-26-266230
SEC(opens sec.gov)
May 274
Bhanji Muna0001061983-26-000062
SEC(opens sec.gov)
Jun 234
Bhanji Muna0001384101-25-000094
SEC(opens sec.gov)
Jun 234
Bhanji Muna0001628280-25-032725
SEC(opens sec.gov)
Jun 174
Bhanji Muna0001384101-25-000079
SEC(opens sec.gov)
Jun 134
Bhanji Muna0000950170-25-086243
SEC(opens sec.gov)
May 154
Bhanji Muna0001127602-25-014556
SEC(opens sec.gov)
May 144
Bhanji Muna0001127602-25-014365
SEC(opens sec.gov)
May 14
Bhanji Muna0000950170-25-061881
SEC(opens sec.gov)
Jan 314
Bhanji Muna0000950170-25-011757
SEC(opens sec.gov)
Jun 174
Bhanji Muna0001628280-24-028602
SEC(opens sec.gov)

Companies

Address

6000 SHORELINE COURT SUITE 300

SOUTH SAN FRANCISCO, CA, 94080